Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    23020162 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
A Study of Trastuzumab Emtansine Versus Capecitabine + Lapatinib in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Trastuzumab emtansine;   Drug: Lapatinib;   Drug: Capecitabine
2 Active, not recruiting Metastatic Breast Cancer in Brazil: Characterization of Patients and Treatments
Condition: Metastatic Breast Cancer
Intervention:

Study has passed its completion date and status has not been verified in more than two years.